|
1
|
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis.
|
Science
|
2009
|
3.39
|
|
2
|
Dynamic persistence of antibiotic-stressed mycobacteria.
|
Science
|
2013
|
3.34
|
|
3
|
Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis.
|
Sci Transl Med
|
2012
|
1.78
|
|
4
|
Disruption of mptpB impairs the ability of Mycobacterium tuberculosis to survive in guinea pigs.
|
Mol Microbiol
|
2003
|
1.62
|
|
5
|
Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis.
|
Antimicrob Agents Chemother
|
2010
|
1.43
|
|
6
|
Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis.
|
Antimicrob Agents Chemother
|
2012
|
1.31
|
|
7
|
Single-cell dynamics of the chromosome replication and cell division cycles in mycobacteria.
|
Nat Commun
|
2013
|
1.21
|
|
8
|
Development of a repressible mycobacterial promoter system based on two transcriptional repressors.
|
Nucleic Acids Res
|
2010
|
1.13
|
|
9
|
Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung.
|
PLoS One
|
2008
|
1.09
|
|
10
|
EspD is critical for the virulence-mediating ESX-1 secretion system in Mycobacterium tuberculosis.
|
J Bacteriol
|
2011
|
0.99
|
|
11
|
Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis.
|
Vaccine
|
2011
|
0.98
|
|
12
|
Assessing the essentiality of the decaprenyl-phospho-d-arabinofuranose pathway in Mycobacterium tuberculosis using conditional mutants.
|
Mol Microbiol
|
2014
|
0.94
|
|
13
|
Mycobacterium tuberculosis EspB binds phospholipids and mediates EsxA-independent virulence.
|
Mol Microbiol
|
2013
|
0.92
|
|
14
|
Phenotypic profiling of Mycobacterium tuberculosis EspA point mutants reveals that blockage of ESAT-6 and CFP-10 secretion in vitro does not always correlate with attenuation of virulence.
|
J Bacteriol
|
2013
|
0.87
|
|
15
|
Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis.
|
Vaccine
|
2005
|
0.86
|
|
16
|
Malachite green interferes with postantibiotic recovery of mycobacteria.
|
Antimicrob Agents Chemother
|
2012
|
0.84
|
|
17
|
Dielectrophoresis-based purification of antibiotic-treated bacterial subpopulations.
|
Lab Chip
|
2014
|
0.83
|
|
18
|
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.
|
J Med Chem
|
2014
|
0.82
|
|
19
|
Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigs.
|
Vaccine
|
2009
|
0.82
|
|
20
|
Recent advances in tuberculosis research in India.
|
Adv Biochem Eng Biotechnol
|
2003
|
0.75
|